Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for Peginterferon alfa-2b (compound)
Most Correlated Studies
- Livers of chronic hepatitis C patients treated with PegIntron (pegIFNα-2b) or Pegasys (pegIFNα-2a)
- Livers of chronic hepatitis C patients treated with peginterferon alfa-2b and ribavirin
- Adjuvant activity in ferrets vaccinated against H1N1 influenza virus
- Drug target sets for approved compounds
- PBMCs from hepatitis C patients undergoing peg-interferon alfa 2b and ribavirin therapy
Most Relevant Literature
- Peginterferon alfa-2b combined with tenofovir disoproxil fumarate induced high clinical cure rate in…
- Population pharmacokinetics of peginterferon alfa-2b in pediatric patients with chronic hepatitis C.
- Vaniprevir plus peginterferon alfa-2b and ribavirin in treatment-naive Japanese patients with hepati…
- Vaniprevir plus peginterferon alfa-2b and ribavirin in treatment-experienced Japanese patients with …
- A Phase 1 trial of autologous monocytes stimulated ex vivo with Sylatron® (Peginterferon alfa-2b) an…
Most Relevant Clinical Trials
- Peginterferon Alfa-2b in Younger Patients With Craniopharyngioma That is Recurrent or Cannot Be Remo…
- Efficacy of Peginterferon Alfa-2b in Previously Untreated Subjects With Chronic Hepatitis B and D Co…
- BIP48 (Peginterferon Alfa 2b 48kDa) Compared With Pegasys® (Peginterferon 2a 40kDa) for Treatment of…
- Boceprevir With Peginterferon Alfa-2b and Ribavirin in the Treatment-naive Patients Infected With Ge…
- Optimized Treatment of Peginterferon Alfa 2a/2b in Treatment Experienced Patients With HBV Related L…
